Skip to contentG
Guided Therapeutics Inc
G
GTHPGuided Therapeutics Inc Q4 2018 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$43.00K$43.00Kderived−58.3% vs Q4 2017 Net Income-$2.74M-$2.74MderivedN/M vs Q4 2017 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Guided Therapeutics Inc · CIK 924515 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived-$42,000N/M Operating Incomederived-$447,000N/M Operating Cash Flowderived-$311,000N/M Margins · derivedGross margin-97.7%+127.6 pt vs Q4 2017
Operating margin-1039.5%−325.9 pt vs Q4 2017
Net margin-6372.1%+572.6 pt vs Q4 2017
ended Dec 31, 2018 · filed May 8, 2019 · 128 d after period end